Understanding of COVID-19 based on current evidence.

Sun, Pengfei; Lu, Xiaosheng; Xu, Chao; Sun, Wenjuan; Pan, Bo

Sun, Pengfei; Lu, Xiaosheng; Xu, Chao; Sun, Wenjuan; Pan, Bo.

Sun P; Department of Plastic Surgery, Zibo Central Hospital, Zibo, China.
Lu X; Department of Plastic Surgery, Affiliated Hospital of Weifang Medical University, Weifang, China.
Xu C; Department of Plastic Surgery, Zibo Central Hospital, Zibo, China.
Sun W; Department of Medicine, People's Hospital of Boxing, Binzhou, China.
Pan B; Department of Plastic Surgery, Plastic Surgery Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

J Med Virol ; 92(6): 548-551, 2020 06.

Article in English | MEDLINE | ID: covidwho-1931

ABSTRACT

ABSTRACT

Since December 2019, a series of unexplained pneumonia cases have been reported in Wuhan, China. On 12 January 2020, the World Health Organization (WHO) temporarily named this new virus as the 2019 novel coronavirus (2019-nCoV). On 11 February 2020, the WHO officially named the disease caused by the 2019-nCoV as coronavirus disease (COVID-19). The COVID-19 epidemic is spreading all over the world, especially in China. Based on the published evidence, we systematically discuss the characteristics of COVID-19 in the hope of providing a reference for future studies and help for the prevention and control of the COVID-19 epidemic.

Subject(s)

Antiviral Agents/therapeutic use; Betacoronavirus/pathogenicity; Communicable Disease Control/organization & administration; Coronavirus Infections/transmission; Pandemics; Pneumonia, Viral/transmission; Adenosine Monophosphate/analogs & derivatives; Adenosine Monophosphate/therapeutic use; Adrenal Cortex Hormones/therapeutic use; Alanine/analogs & derivatives; Alanine/therapeutic use; Animals; Betacoronavirus/drug effects; Betacoronavirus/genetics; COVID-19; China/epidemiology; Chiroptera/virology; Coronavirus Infections/diagnosis; Coronavirus Infections/drug therapy; Coronavirus Infections/mortality; Disease Management; Humans; Oseltamivir/therapeutic use; Pneumonia, Viral/diagnosis; Pneumonia, Viral/drug therapy; Pneumonia, Viral/mortality; SARS-CoV-2; Survival Analysis

Keywords

2019-nCoV; COVID-19; SARS-CoV-2; coronavirus; epidemiology; pneumonia

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Communicable Disease Control / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Diagnostic study / Observational study / Prognostic study Limits: Animals / Humans Country/Region as subject: Asia Language: English Journal: J Med Virol Year: 2020 Document Type: Article Affiliation country: Jmv.25722

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google